My take after listening to interview:
We have so many different avenues to revenue that it's worth taking the time now to get the mix right.
Not many other companies have this diversification advantage but with that it makes it more difficult to balance these opportunities.
We know that the DFS timeline doesn't affect the mining application timeline so I'm happy for management and James to take their time and get the strategy for the next few years spot on.
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-15535
Featured News
Add ADN (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.57M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $19.77K | 3.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 19595227 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 7890877 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 19595227 | 0.006 |
44 | 28815157 | 0.005 |
12 | 11398750 | 0.004 |
8 | 13134995 | 0.003 |
7 | 15650497 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 7890877 | 23 |
0.008 | 8368677 | 19 |
0.009 | 14861776 | 19 |
0.010 | 4800882 | 8 |
0.011 | 27266522 | 7 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online